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Abstract 
Probiotics are live microbes in the form of dried or fermented cells that are highly benefi-
cial for human health. The food industry has been revolutionised due to introduction of 
potential probiotic organisms in a varied formulations derived from mostly dairy products. 
Isolation of probiotic microbes from unexplored non-dairy sources is gaining attention 
these days. In the present study, six potential probiotic isolates from non-dairy sources 
were obtained that are also biocompatible with each other. Out of these, five isolates 
were gram positive rod shaped and one was gram negative rod shaped. These isolates 
were able to grow in presence of lysozyme, low pH and bile salts with good adherence 
ability. The market for probiotic microorganisms from unconventional products is acceler-
ating to deal with lactose intolerant people. These probiotic attribute studies revealed their 
potential to be exploited at industrial scale.  
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INTRODUCTION 
Probiotics are generally live microbes that can be 
isolated from dietary supplements, food products 
and drugs and have a beneficial effect on human 
health (Sanders et al., 2003; Parvez et al., 2006). 
For probiotic delivery numerous food products like 
yoghurt, cheese, cereals, smoothies, juices, fer-
mented and unfermented milks are available in 
the market. In addition to these sources various 
dried and packaged microbes in the form of tab-
lets, capsules and also as dietary supplements 
are available in the market. These commercial 
health supporting products are either single micro-
organism or may be combination of more than 
one microbe. In human adults, bacterial divisions 
that dominate accounting for more than 90% mi-
crobiota are Bacteriodes and Firmicutes. Other 
important bacteria include Proteobacteria, Fuso-
bacteria, Acitonobacteria and Verrucomicrobia. 
According to the 2015 Grand View Research re-
port the global share of probiotics in industries 
reached near about US $ 32.06 billion 
(Merenstein et al., 2017) 
Probiotics are exploited these days to maintain a 
good, healthy balance of gut bacterial ecosystem. 
Microbial imbalance is a change in diversity rich-
ness and stability of the gut microbiota. This mi-
crobial imbalance or dysbiosis can lead to various 
intestinal disorders like bowl syndrome, colorectal 
cancer etc. This can be prevented with the use of 
probiotics in diet (Vasiljevic et al., 2008). These 
sources have capability to improve intestinal micro 
flora of ileum and colon (Ezendam  et al., 2006; 
Collado et al., 2007; Markowiak et al., 2017)  and 
are considered as microbial dietary adjuvant that 
improve host mucosal and systemic immunity 
(Colbey et al. 2018). The existence of normal mi-
cro-flora in gastrointestinal tract helps to maintain 
the integrity of the epithelial barrier and also help 
to develop mucosal immunity (O’Hara et al., 
2007). Any disturbance in normal micro-flora may 
lead to pathogenesis of numerous disorders such 
as inflammatory bowel disorder, autoimmune dis-
eases, colon cancer, gastric ulcers, cardiovascular 
diseases and obesity (Bien et al., 2013). There-
fore, it becomes very important to restore the nor-
mal micro-flora and one way to regain it is through 
the use of prebiotics and probiotics. Prebiotics are 
the fermented ingredients that cause changes in 
the composition or activity of gut microflora in a 
specific way. These are non-digestible by the host 
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but provide health benefits via positive impact on 
the native gastrointestinal microbes. Mostly prebi-
otics are provided to the host as ingredients of 
different food like cereals, biscuits, chocolates, 
bread spreads and dairy products.  
There are numerous barriers in the human body 
with antimicrobial activity that prevent the growth 
of external microorganisms. For example lyso-
zyme, present in saliva exhibit antibacterial activi-
ty against Gram positive bacteria and breaks the 
cell wall of bacteria. Other barriers are high acidic 
conditions and high bile salt concentration, In or-
der to provide health benefits probiotic strains 
should have capability to survive these conditions 
(Munoz-Quezada et al., 2013). The probiotic bac-
teria must be hydrophobic enough to adhere well 
to the ileum and colon wall. Lactobacillus and 
Bifidobacterium are the most commonly used mi-
croorganisms as probiotics which are found in 
large numbers in gut of healthy humans and have 
GRAS (Generally Regarded As Safe) status 
(Shokryazdan et al., 2014).  
Now days, research has been focused for isolat-
ing the probiotic strains from non-dairy sources 
like soil, fruit juices, grains etc (Sornplang et al., 
2016). Keeping above points in mind the work 
was designed to screen probiotic bacteria from 
unconventional food sources to utilize them com-
mercially specifically for lactose-intolerant people.  
MATERIALS AND METHODS 
Isolation of probiotic strains from unconven-
tional sources: The unconventional samples like 
brockley (BR), carrot (CR), cucumber (CC), white-
gram (WG), moong (MG), shakkar (SH), green 
beans (GB), honey (HN), papaya (PP), wheat 
(WH) were collected. These samples were serially 
diluted ten-folds and dilutions were spread on De 
Man, Rogosa and Sharpe (MRS) agar medium 
(proteose peptone 10gm, beef extract 10gm, 
yeast extract 5gm, dextrose 20gm, polysorbate 
(80) 1gm,  ammonium citrate 2gm, sodium ace-
tate 5gm, magnesium sulphate 0.1gm, manga-
nese sulphate 0.050gm, dipotassium phosphate 
2gm, agar 12gm, final pH of 6.5) 
The plates were incubated at 37°C for 24h-
48h.The plates were observed for two days to 
analyze any appearance if colonies on each plate. 
The isolates were further purified by streak meth-
od on MRS agar plates followed by incubation at 
37°C for 24h. The purified isolates were main-
tained on MRS agar slants at 4°C (Prawan et al., 
2017). 
Identification of different probiotic bacteria: 
Gram staining and biochemical test (citrate test, 
urease test, indole test, MR (Methyl Red) test, VP 
(Voges Proskauer) test, catalase test, TSI (triple 
sugar iron) test were performed for characteriza-
tion of selected isolates.  
Citrate test (Simmons, 1926):  Simmons citrate 
media (24.28 gm) was dissolved in water and vol-
ume made up to 1L and boiled. It was dispensed 
in sugar tubes and autoclaved at 15psi for 15 
minutes. The media was allowed to settle as 
slants. The tubes were streaked using a loop with 
24h old culture. The tubes were incubated at 37 °
C for 24h and observed for the colour change. 
Urease test (Christensen, 1946): Peptone and 
agar was dissolved in water and volume make up 
to 1L. This was autoclaved at 15psi for 15 
minutes; to the molten media added urea and 
phenol red mixed to it. Dispensed in sugar tubes 
and allowed to settle media as slants. The tubes 
were inoculated with 24h old culture by streaking 
on the slant. The tubes were incubated at 37ºC for 
24h and change in colour was noted. 
Indole test (Isenberg et al., 1958): Prepared 
trypton broth was autoclaved and culture was in-
oculated in trypton broth in a test tube after that 
test tube was incubated at 37ºC  for 24h.1 ml of 
kovac’s reagent was added in inoculated test 
tube. The test tube was shaken well and allowed 
to stand to permit the reagent to come on the top 
of test tube.  Appearance of red ring or red layer 
was observed.  
MR test: Prepared MR broth was added in test 
tube and subjected to be autoclaved. The loopful 
culture was inoculated in a test tube. The tubes 
were incubated at 37ºC for 24h. 5 drops of methyl 
red solution was added in inoculated test tube and 
change in colour from yellow to red indicates posi-
tive test. 
VP test (Voges et al., 1898): MRVP broth was 
prepared and poured in test tubes and autoclaved. 
The culture was inoculated in test tube containing 
broth. The test tubes were incubated at 37ºC for 
24h. 12 drops of V-P-1 and 2-3 drops of V-P-2 
reagent were added in inoculated tubes and kept 
for some time. The change in colour from yellow 
to red was taken as positive. 
Catalase test (Taylor et al., 1972): The clean 
glass slides were used. A drop of hydrogen perox-
ide was placed on it. Using a loop/ toothpick a 
culture was picked from a 24h old culture and 
mixed with the drop of H2O2 and noted for the ap-
pearance of bubbles. 
TSI test:  TSI agar was inoculated by first stab-
bing into the center of the medium up to the tube 
bottom followed by streaking on the agar slant 
surface with 24h grown culture. The tubes were 
incubated at 37ºC for 18-24 h.  
Probiotic attributes: The selected 10 isolates 
(BR3, CR1, CC4, CH1, MG6, SH1, GB4, HN1, 
PP1, WH2) were further studied for various probi-
otic attributes like low pH tolerance, bile tolerance, 
lysozyme tolerance, bacterial surface hydrophobi-
city and anti-microbial activity (Trikha et al., 2015). 
i.) Lysozyme tolerance: Ten selected isolates 
were checked for lysozyme tolerance by inoculat-
ing them in MRS broth supplemented with 1% 
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lysozyme (Saran et al., 2012). The inoculated me-
dia was incubated for 4h at 37ºC under static con-
dition. The control samples inoculated with each 
isolate (no lysozyme) were incubated at same 
conditions. After each hour, the small amount of 
sample was withdrawn for analysis of growth us-
ing spectrophotometer (UV/ VIS Spectrophotome-
ter UV 3000+, Lab, India) at 600nm.  
ii). Low pH tolerance: The probiotic microorgan-
isms should be acid tolerant therefore the toler-
ance of isolates to acidic conditions was checked 
by growing them in MRS broth (pH 2.5). The me-
dium was inoculated with selected ten isolates 
(grown for 16h) and incubated for 4h at 37ºC un-
der static condition. After each hour, the small 
amount of sample was withdrawn for analysis of 
growth using spectrophotometer (UV/ VIS Spec-
trophotometer UV 3000+, Lab, India) at 600nm.  
iii). Bile tolerance: The tolerance of microorgan-
isms was checked by growing them in MRS broth 
supplemented with 0.5% ox-bile .The inoculated 
medium was incubated for 4h at 37ºC under static 
condition. After each hour, the small amount of 
sample was withdrawn for analysis of growth us-
ing spectrophotometer (UV/ VIS Spectrophotome-
ter UV 3000+, Lab, India) at 600nm.  
iv). Bacterial surface hydrophobicity: Hydro-
phobic interactions were tested using xylene-
water system (BATH- bacterial adherence to hy-
drocarbons). Hydrophobicity tests the ability of 
microorganism to adhere and colonize ileum/colon 
to confer health benefits. In order to test hydro-
phobicity the isolates were grown in MRS broth for 
16h-18h at 37ºC followed by centrifugation at 
10,000 rpm for 10 minutes. The pellet obtained 
after centrifugation was washed and suspended in 
PBS (phosphate buffer saline) buffer. The absorb-
ance of the suspension was adjusted to 1.0 at 
560nm and 600µl of xylene was added. 
V). Antimicrobial activity: The agar well diffusion 
method was used for antimicrobial activity of pro-
biotics against selected strains Escherichia coli 
(MTCC 2961), Staphylococcus aureus (MTCC 
3160). The isolates were grown in MRS broth for 
16h-18h at 37ºC followed by centrifugation at 
10,000 rpm for 10 minutes. The supernatant was 
collected after centrifugation. The MHA plates 
were spread with test pathogens and 100µl of su-
pernatant was added to the well. The plates were 
incubated for 24h at 37ºC (Valgas et al., 2007). 
Biocompatibility test: The biocompatibility of se-
lected isolates was tested to ensure that they don’t 
cause inhibition of each other. The test was per-
formed by perpendicular streaking of isolate to 
each other separated by 0.5 mm distance on on 
MRS agar plates. After incubation at 37 ºC for 24h 
the plates were checked for the growth of isolates 
(Trikha et al., 2015).  
RESULTS 
In the present study, different non-dairy sources 
were collected for isolation of probiotic microorgan-
isms. Each sample was processed by serial dilu-
tion method and different number of isolates was 
obtained. Table 1 shows the non-dairy sources 
and number of isolates obtained from each sample 
after incubation on agar plates. Total of 34 isolates 
were obtained from all these samples. Out of 
which, 10 isolates were selected for further studies 
on basis of colony morphology and gram staining. 
The selected isolates were subjected to gram 
staining and biochemical characterization. Table 2 
summarizes the gram character of the selected 
isolates from different unconventional sources.  
Out of 10 isolates, 8 were gram positive rods and 2 
were gram negative rods. The figure 1 and table 3 
summarized the biochemical test of the selected 
isolates. 
Probiotic attributes: The selected 10 isolates 
were tested for probiotic characteristics such as to 
lysozyme tolerance, acid tolerance, bile tolerance 
and cell surface hydrophobicity. In the lysozyme 
tolerance test, all the isolates showed nearly equal 
significantly good growth in the presence of lyso-
zyme suggesting the ability of these isolates to 
tolerate lysozyme. These isolates were further an-
alyzed for growth in low pH conditions. Out of the-
se isolates, CC4 and PP1 showed best growth at 
acidic conditions. The isolates BR3, CC4, CH1 and 
PP1 showed maximum tolerance to bile. Hydro-
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Fig.1. Results of Biochemical tests (a) TSI test (b) 
Citrate test (c) MR (methyl red) test (d) VP test. 
Fig. 2. Biocompatibility test of isolates. 
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phobicity assay was performed to analyse the 
adherence ability of each isolate. Among the 10 
isolates, 6 isolates (BR3, CC4, CH1, MG6, GB4 
and PP1) showed good hydrophobicity. The iso-
lates were further selected for antimicrobial activi-
ty against Escherichia coli, Staphylococcus aure-
us but none of them showed the antimicrobial na-
ture. Biocompatibility test was performed to test 
that consortium of selected probiotic isolates can 
be prepared further (figure 2).  All 6 isolates were 
biocompatible with each other because no growth 
inhibition of isolates was observed. 
The isolates were further selected for antimicrobi-
al activity against Escherichia coli, Staphylococ-
cus aureus. All the selected 10 isolates showed 
the complete tolerance to lysozyme, acid and bile. 
Out of 10 isolates (BR3, CR1, CC4, CH1, MG6, 
SH1, GB4, HN1, PP1, WH2), 6 isolates showed 
significant hydrophobicity as compared to others. 
The selected 6 isolates (BR3, CC4, CH1, MG6, 
GB4 and PP1) do not possess antimicrobial activi-
ty against test pathogens Escherichia coli and 
Staphylococcus aureus. Biocompatibility test was 
performed to test that consortium of selected pro-
biotic isolates can be prepared further (figure 2).  
All 6 isolates were biocompatible with each other. 
DISCUSSION 
Probiotics are defined as “live microorganisms 
which when administered in adequate amounts 
confer a health benefit on the host” (by FAO and 
WHO in 2001). They have gained immense atten-
tion owing to their beneficial effects on human 
health. They are considered a healthy alternative 
to treat and prevent numerous diseases in hu-
mans like bowl syndrome, gastritis and several 
urogenital disorders (Vasile et al., 2011). Antibiotic 
associated studies have suggested that lactobacil-
li given at high concentration were potent enough 
to kill HIV-1 thus revealing the possible role of 
probiotics in preventing transmission of diseases 
like STD’s and AIDS. The probiotic agents may 
provide prototype antimicrobial substances that 
will be useful for pharmaceutical companies in the 
development of new antibiotics (Vasile et al., 
2011). 
Bacterial isolates were identified through different 
biochemical tests such as citrate, catalase, indole, 
urease, MRVP and triple sugar test (TSI) etc. The 
selected 10 isolates were further studied for their 
probiotic attributes such as acid, bile and lyso-
zyme tolerance, cellular hydrophobicity and anti-
microbial activity. 
The probiotic organisms should have the ability to 
survive in the acidic environment of human stom-
ach. All the selected isolates showed tolerance to 
acidic conditions (pH 2.5). Tokat et al., 2015 stud-
ied the tolerance to acid by numerous lactic acid 
bacteria and reported that highest tolerance (85%) 
was showed by Lactobacillus plantarum MF303. 
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Table 1. Different unconventional sources of probiotics and number of isolates from each source. 
S.N. Unconventional sources of probiotics No. of isolates 
1 Brockley (BR) 4 (BR1,BR2,BR3,BR4) 
2 Carrot (CR) 2 (CR1,CR2) 
3 Cucumber (CC) 5 (CC1,CC2,CC3,CC4,CC5) 
4 Channe (CH) 4 (CH1,CH2,CH3,CH4) 
5 Moong (MG) 7 (MG1,MG2,MG3,MG4,MG5,MG6,MG7) 
6 Shakkar (SH) 3 (SH1,SH2,SH3) 
7 Green beans (GB) 4 (GB1,GB2,GB3,GB4) 
8 Honey (HN) 1 (HN1) 
9 Papaya (PP) 2 (PP1,PP2) 
10 Wheat (WH) 2 (WH1,WH2) 
Table 2. Gram character of selected isolates. 
S.N. Isolate No. Gram Character 
1 BR3 Gram positive rod shaped 
2 CR1 Gram positive  rod shaped 
3 CC4 Gram positive  rod shaped 
4 CH1 Gram negative  rod shaped 
5 MG6 Gram positive rod shaped 
6 SH1 Gram negative  rod shaped 
7 GB4 Gram positive rod shaped 
8 HN1 Gram positive rod shaped 
9 PP1 Gram positive rod shaped 
10 WH2 Gram positive rod shaped 
Table 3. Biochemical characterization of selected isolates. 
S.N. Isolate No. Catalase Citrate Indole MR TSI Urease VP 
1 BR3 - + - + + - - 
2 CR1 - + - + + - - 
3 CC4 - + - + + - - 
4 CH1 + - - + + - + 
5 MG6 + - - + + - + 
6 SH1 + - - + + - - 
7 GB4 + + - + + - - 
8 HN1 - + - + + - - 
9 PP1 - + - + + - - 
10 WH2 - + - + - - - 
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Survival in the presence of bile salts is also crucial 
to qualify as a potential probiotic organism (Das et 
al., 2014). All the selected isolates showed toler-
ance to 0.5% ox-bile. Resistance to lysozyme is 
an important probiotic attribute and therefore the 
isolates were tested for lysozyme tolerance. All 
the isolates showed tolerance to lysozyme. Cellu-
lar hydrophobicity determines the adherence of 
the bacterial (probiotic) cells to the intestinal wall. 
The hydrophobicity studies were carried out for 
the selected isolates and six isolates (BR3, CC4, 
CH1, MG6, GB4 and PP1) showed significant 
hydrophobicity. Biocompatibility tests have re-
vealed that all the isolates were compatible with 
each other. 
Conclusion 
Probiotic microorganisms have been recognised 
as a healthy alternative to treat numerous diseas-
es in both humans and animals. The use of probi-
otics is accelerating as this is a considerable ap-
proach to decrease drug resistance cases in both 
humans and animals that occurs due to random 
and overuse of antibiotics. In the present study 
total 34 isolates were obtained from unconven-
tional sources. Out of which 10 were selected for 
studying attributes to qualify as potential probiotic.  
Six isolates (BR3, CC4, CH1, MG6, GB4 and 
PP1) showed good probiotic characteristic to ex-
plore at commercial level. These isolates were 
found to be biocompatible so can be used to pre-
pare a healthy cocktail. Further studies dealing 
with molecular characterization and in vivo studies 
for evaluation of their effect on digestive and im-
mune system will make them more industry rele-
vant. 
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